Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT02582333
Eligibility Criteria:
Inclusion Criteria:
1. Age \> or = 20 years old
2. Chronic hepatitis B patients who received tenofovir or entecavir as their first anti-HBV therapy
3. Patients who have received nucleos(t)ide analogue therapy for \> 3 years or reached the stopping criteria of APASL ( HBeAg+ patients: HBeAg seroconversion \> 12 months; HBeAg - patients: HBV DNA undetectable \> 12 months)
Exclusion Criteria:
1. History of liver cirrhosis or hepatocellular carcinoma
2. Recipients of liver transplantation
3. Concurrent malignancies (except curable skin cancers)
4. Concomitant use of immunosuppressants
5. Coinfection with HCV, HDV, HIV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02582333
Study Brief:
Protocol Section:
NCT02582333